15. november 2007

Ainult tellijatele

(BW)(PFIZER-1-2-3-4-5-6)(PFE)(COLY) Pfizer to Acquire Coley Pharmaceutical Group Acquisition Will Expand Pfizer's Investment in Vaccines- Broaden Scope of Research in a Number of Key Therapeutic AreasBusiness Editors/Healthcare Editors

<em><br /></em>NEW YORK amp; WELLESLEY- Mass.--(BUSINESSWIRE)--Nov. 16- 2007--Pfizer Inc (NYSE: PFE) announced today it hasentered into an agreement to acquire Coley Pharmaceutical Group-Inc. (NASDAQ: COLY)- a publicly-held biopharmaceutical companyspecializing in vaccine adjuvant technology and a new class ofimmunomodulatory drug candidates designed to fight cancers- allergyand asthma disorders- and autoimmune diseases.